Clinical Trial Update: Study of ARO-AAT in Normal Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study of ARO-AAT in normal adult volunteers has completed. The trial relates to alpha-1 antitrypsin deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• ARO-AAT

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Alpha 1-Antitrypsin Deficiency | Phase 1 | Status: COMPLETED